Post by Sulzer Chemtech

Everything you need to know about #industrialprocesswater in #pharma manufacturing. Process water from API production is not ordinary wastewater. It carries solvents, complex organics, and compounds that are acutely toxic to biological treatment, and it needs to be handled differently. Here is what that means in practice: ☑️ It is not a wastewater problem. The moment you treat it like one, your downstream treatment system becomes inefficient. ☑️ Biology has hard limits. Solvents and organics from API wash water do not biodegrade in your treatment plant. They disrupt it, often gradually, which makes the root cause hard to trace. ☑️ Regulations are tightening. IED 2.0 and the Urban Wastewater Treatment Directive are raising discharge requirements across the EU. Compliance windows are shorter than most investment cycles allow for. ☑️ Pretreatment is proven. Stripping and liquid-liquid extraction achieve greater than 99% removal of toxic organics before they reach the biozone. With systems running stably for over a decade. ☑️ Pilot testing de-risks the investment. Real stream data beats assumptions every time. Testing your actual stream before committing to CAPEX is not an extra step, it is the step. ☑️ Go beyond compliance with recovery. Solvents that look like a disposal liability often carry real economic value once you run the numbers. The smartest process water strategy starts upstream. Learn more: https://bit.ly/4uEUcgD #wastewater #sustainability #API #chemical #IED